Gene · 3799
Papers2,390
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
221 to 240 of 2,390
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Targeted therapies in non-small cell lung cancer: present and future. | Fac Rev | 2023 | 37675274 | PubTator, text mining | PubMed |
| DAB2IP suppresses invadopodia formation through destabilizing ALK by interacting with USP10 in breast cancer. | iScience | 2023 | 37664607 | PubTator, text mining | PubMed |
| Mutation status analysis of 58 patients with advanced ALK fusion gene positive non small cell lung cancer. | BMC Pulm Med | 2023 | 37658352 | PubTator, text mining | PubMed |
| Combined large cell neuroendocrine carcinoma, lung adenocarcinoma, and squamous cell carcinoma: a case report and review of the literature. | J Cardiothorac Surg | 2023 | 37653509 | PubTator, text mining | PubMed |
| The Proteome Profile of Olfactory Ecto-Mesenchymal Stem Cells-Derived from Patients with Familial Alzheimer's Disease Reveals New Insights for AD Study. | Int J Mol Sci | 2023 | 37628788 | PubTator, text mining | PubMed |
| RET-Altered Cancers-A Tumor-Agnostic Review of Biology, Diagnosis and Targeted Therapy Activity. | Cancers (Basel) | 2023 | 37627175 | PubTator, text mining | PubMed |
| Dipeptidyl-Aminopeptidases 8 and 9 Regulate Autophagy and Tamoxifen Response in Breast Cancer Cells. | Cells | 2023 | 37626841 | PubTator, text mining | PubMed |
| Mitochondrial heterogeneity in diseases. | Signal Transduct Target Ther | 2023 | 37607925 | PubTator, text mining | PubMed |
| The efficacy and safety of selective RET inhibitors in RET fusion-positive non-small cell lung cancer: a meta-analysis. | Invest New Drugs | 2023 | 37603207 | PubTator, text mining | PubMed |
| Targeted treatments after chemoradiotherapy failure in a patient with relapsed, advanced non‑small cell lung cancer with on‑therapy circulating tumor biomarker monitoring: A case report. | Oncol Lett | 2023 | 37600327 | PubTator, text mining | PubMed |
| TUBB3 and KIF21A in neurodevelopment and disease. | Front Neurosci | 2023 | 37600020 | PubTator, text mining | PubMed |
| Complete loss of TP53 and RB1 is associated with complex genome and low immune infiltrate in pleomorphic rhabdomyosarcoma. | HGG Adv | 2023 | 37593416 | PubTator, text mining | PubMed |
| Milton assembles large mitochondrial clusters, mitoballs, to sustain spermatogenesis. | Proc Natl Acad Sci U S A | 2023 | 37579146 | PubTator, text mining | PubMed |
| A narrative review of methods for the identification of ALK fusions in patients with non-small cell lung carcinoma. | Transl Lung Cancer Res | 2023 | 37577307 | PubTator, text mining | PubMed |
| Detection of resistance mutations in patients with anaplastic lymphoma kinase-rearranged lung cancer through liquid biopsy. | Transl Lung Cancer Res | 2023 | 37577301 | PubTator, text mining | PubMed |
| Recent advances in non-small cell lung cancer targeted therapy; an update review. | Cancer Cell Int | 2023 | 37568193 | PubTator, text mining | PubMed |
| A humanized Caenorhabditis elegans model of hereditary spastic paraplegia-associated variants in KLC4. | Dis Model Mech | 2023 | 37565267 | PubTator, text mining | PubMed |
| Impaired Lysosome Reformation in Chloroquine-Treated Retinal Pigment Epithelial Cells. | Invest Ophthalmol Vis Sci | 2023 | 37548963 | PubTator, text mining | PubMed |
| Control of motor landing and processivity by the CAP-Gly domain in the KIF13B tail. | Nat Commun | 2023 | 37543636 | PubTator, text mining | PubMed |
| Mapping the MOB proteins' proximity network reveals a unique interaction between human MOB3C and the RNase P complex. | J Biol Chem | 2023 | 37536630 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/3799/papers?page=12